They advertise low costs, round-the-clock service, easy access, immediate appointment scheduling, professional healthcare and prescriptions available at short notice. We are talking about telehealth providers. In the US, they have sprung up like mushrooms against the backdrop of COVID-19 restrictions, when in-person visits to the doctor were made difficult. The expansion of their use is being vigorously promoted. In fact, telehealth services could be a useful addition to healthcare provision. In their current form, however, they offer pharmaceutical interests a welcome gateway to expanding the business with disease. In doing so, telehealth providers expose the real weakness in the current healthcare system: the lack of focus on cause-based treatment. […]